ATE192041T1 - Arzneimittel zur prophylaxe und behandlung von katarakt - Google Patents

Arzneimittel zur prophylaxe und behandlung von katarakt

Info

Publication number: ATE192041T1
Authority: AT; Austria
Prior art keywords: pct; treatment; prophylaxis; cataracts; methylbenzoylamino
Prior art date: 1993-02-23

Application number

AT94907086T

Other languages

English (en)

Inventor

Yoshitaka Yamamura

Tatsuya Yamashita

Shigeki Nakamura

Toshiyuki Onogawa

Yoshihisa Yamada

Kenji Tsujimae

Hidenori Ogawa

Toyoki Mori

Michiaki Tominaga

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-02-23

Filing date

1994-02-22

Publication date

2000-05-15

1994-02-22 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2000-05-15 Application granted granted Critical

2000-05-15 Publication of ATE192041T1 publication Critical patent/ATE192041T1/de

Links

208000002177 Cataract Diseases 0.000 title abstract 3
238000011321 prophylaxis Methods 0.000 title abstract 3
238000011282 treatment Methods 0.000 title abstract 3
LISFMEBWQUVKPJ-UHFFFAOYSA-N carbostyril Natural products C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
-1 carbostyril compound Chemical class 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
WRNXUQJJCIZICJ-UHFFFAOYSA-N mozavaptan Chemical compound C12=CC=CC=C2C(N(C)C)CCCN1C(=O)C(C=C1)=CC=C1NC(=O)C1=CC=CC=C1C WRNXUQJJCIZICJ-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
GYHCTFXIZSNGJT-UHFFFAOYSA-N tolvaptan Chemical compound CC1=CC=CC=C1C(=O)NC(C=C1C)=CC=C1C(=O)N1C2=CC=C(Cl)C=C2C(O)CCC1 GYHCTFXIZSNGJT-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT94907086T 1993-02-23 1994-02-22 Arzneimittel zur prophylaxe und behandlung von katarakt ATE192041T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP3289693		1993-02-23
PCT/JP1994/000265 WO1994018975A1 (en)	1993-02-23	1994-02-22	Agent for prophylaxis or treatment of cataract

Publications (1)

Publication Number	Publication Date
ATE192041T1 true ATE192041T1 (de)	2000-05-15

Family

ID=12371661

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94907086T ATE192041T1 (de)	1993-02-23	1994-02-22	Arzneimittel zur prophylaxe und behandlung von katarakt

Country Status (13)

Country	Link
US (1)	US5827862A (de)
EP (1)	EP0686035B1 (de)
KR (1)	KR100197065B1 (de)
CN (1)	CN1120810A (de)
AT (1)	ATE192041T1 (de)
AU (1)	AU668024B2 (de)
CA (1)	CA2156497A1 (de)
DE (1)	DE69424156T2 (de)
DK (1)	DK0686035T3 (de)
ES (1)	ES2145823T3 (de)
MX (1)	MX9401350A (de)
TW (1)	TW354762B (de)
WO (1)	WO1994018975A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0735895B1 (de) *	1993-11-19	2006-01-18	The University Of Sydney	Verfahren zur prophylaxe oder kontrolle des katarakts
DE19748763A1 (de) *	1997-11-05	1999-05-06	Hans Peter Zenner	Verwendung von Vasopressin-Antagonisten
US7030149B2 (en)	2002-04-19	2006-04-18	Allergan, Inc.	Combination of brimonidine timolol for topical ophthalmic use
TWI322689B (en)	2003-02-24	2010-04-01	Otsuka Pharma Co Ltd	Method for treating severe heart failure and medicament therefor
US7220422B2 (en) *	2003-05-20	2007-05-22	Allergan, Inc.	Methods and compositions for treating eye disorders
US20050059583A1 (en)	2003-09-15	2005-03-17	Allergan, Inc.	Methods of providing therapeutic effects using cyclosporin components
US20070015691A1 (en) *	2005-07-13	2007-01-18	Allergan, Inc.	Cyclosporin compositions
PL2261215T3 (pl)	2005-09-02	2015-06-30	Otsuka Pharma Co Ltd	Sposób wytwarzania związków benzoazepinowych lub ich soli
US9522153B2 (en)	2009-12-22	2016-12-20	Allergan, Inc.	Compositions and methods for lowering intraocular pressure
CN107915752B (zh) *	2017-11-14	2018-09-18	牡丹江医学院	一种治疗白内障的药物及其制备方法
WO2020123312A1 (en)	2018-12-09	2020-06-18	Weinberg Assa	Method to prevent and treat macular degeneration by vasodilators
WO2020123852A1 (en) *	2018-12-15	2020-06-18	Weinberg Assa	Method to prevent and treat ocular cataract by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers
KR20240136175A (ko)	2023-03-06	2024-09-13	이규호	안건강 통합 관리 시스템

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0382185B1 (de) *	1989-02-10	1994-06-15	Otsuka Pharmaceutical Co., Ltd.	Carbostyrilderivate
JP2905909B2 (ja) *	1991-04-19	1999-06-14	大塚製薬株式会社	バソプレシン拮抗剤
KR0167349B1 (ko) *	1989-10-20	1999-02-18	오스카 아끼히꼬	벤조헤테로 고리 화합물

1994
- 1994-02-16 TW TW083101214A patent/TW354762B/zh active
- 1994-02-22 DK DK94907086T patent/DK0686035T3/da active
- 1994-02-22 DE DE69424156T patent/DE69424156T2/de not_active Expired - Fee Related
- 1994-02-22 WO PCT/JP1994/000265 patent/WO1994018975A1/en not_active Ceased
- 1994-02-22 MX MX9401350A patent/MX9401350A/es unknown
- 1994-02-22 ES ES94907086T patent/ES2145823T3/es not_active Expired - Lifetime
- 1994-02-22 US US08/507,333 patent/US5827862A/en not_active Expired - Fee Related
- 1994-02-22 AU AU60460/94A patent/AU668024B2/en not_active Ceased
- 1994-02-22 EP EP94907086A patent/EP0686035B1/de not_active Expired - Lifetime
- 1994-02-22 CN CN94191767A patent/CN1120810A/zh active Pending
- 1994-02-22 CA CA002156497A patent/CA2156497A1/en not_active Abandoned
- 1994-02-22 KR KR1019950703554A patent/KR100197065B1/ko not_active Expired - Fee Related
- 1994-02-22 AT AT94907086T patent/ATE192041T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1120810A (zh)	1996-04-17
KR100197065B1 (ko)	1999-06-15
DK0686035T3 (da)	2000-08-07
US5827862A (en)	1998-10-27
EP0686035A1 (de)	1995-12-13
EP0686035B1 (de)	2000-04-26
CA2156497A1 (en)	1994-09-01
DE69424156D1 (de)	2000-05-31
WO1994018975A1 (en)	1994-09-01
KR960700719A (ko)	1996-02-24
AU6046094A (en)	1994-09-14
ES2145823T3 (es)	2000-07-16
AU668024B2 (en)	1996-04-18
TW354762B (en)	1999-03-21
DE69424156T2 (de)	2000-09-14
MX9401350A (es)	1994-08-31

Similar Documents

Publication	Publication Date	Title
ATE192041T1 (de)	2000-05-15	Arzneimittel zur prophylaxe und behandlung von katarakt
HUT76473A (en)	1997-09-29	5-(2-imidazolidinylidene-amino)benzimidazole derivatives, pharmaceutical compositions containing them and their use as alpha-2 adrenoreceptor agonists
DE59409312D1 (de)	2000-05-31	Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
ATE195117T1 (de)	2000-08-15	1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
DE69521424D1 (de)	2001-07-26	Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption
NO971470D0 (no)	1997-04-01	Nye pyrimidon-derivater med fungicid aktivitet
DE69332259D1 (de)	2002-10-10	Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung
NZ236293A (en)	1992-10-28	1-(alkyl or alkoxyalkyl)-4-phenyl piperidine-4-carboxylic acid amide derivatives; preparatory processes and pharmaceutical compositions
AU3563695A (en)	1996-05-31	Novel piperidine derivatives with paf antagonist activity
NO944892D0 (no)	1994-12-16	N-substituerte 3-azabicyklo (3.2.0) hepatanderivater som neuroleptika osv.
BR9408244A (pt)	1997-05-27	Derivados de azabiciclo[3.2.0]heptano N-substituídos
AU3116595A (en)	1996-03-04	N-substituted azabicycloheptane derivatives, the preperation and use thereof
DK0866711T3 (da)	2006-11-27	Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
AU5819394A (en)	1994-08-15	N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
PL313037A1 (en)	1996-05-27	Phenoxphenylocyclopententenylohydroxyureas
DE69318715D1 (de)	1998-06-25	Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
AU3749195A (en)	1996-05-06	Bis-2-aminopyridines, preparation method therefor and use tereof for controlling parasitic infections
EP1364953A4 (de)	2004-06-09	Triazolochinazolin- und pyrazolotriazolopyrimidinderivate, medizinische zusammensetzungen, mittel mit adenosin-a3-rezeptoraffinität, mittel, die den augeninnendruck senken, zubereitungen zur prävention und behandlung von glaukom und verfahren zur senkung des augeninnendrucks"
ATE215824T1 (de)	2002-04-15	Mittel zur verminderung des augeninnendrucks
MX9701010A (es)	1997-05-31	Un preventivo y un remedio para herida y/o inflamacion oftalmica.
EE03488B1 (et)	2001-08-15	Meetod anhüdroekgoniini estrite valmistamiseks

Legal Events

Date	Code	Title	Description
2000-11-15	UEP	Publication of translation of european patent specification
2002-05-15	REN	Ceased due to non-payment of the annual fee